Small Cell Lung Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of Low-Dose Radiotherapy Concurrent Cisplatin/Carboplatin Plus Etoposide With Serplulimab for Patients With ES-SCLC
Condition: Extensive-stage Small-cell Lung Cancer Interventions: Drug: serplulimab; Drug: Cisplatin; Drug: Carboplatin; Drug: Etoposide; Radiation: Thoracic radiation therapy (TRT) Sponsor: Sichuan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials

First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Condition: Small Cell Lung Cancer Extensive Stage Intervention: Drug: Pembrolizumab, Plinabulin plus Etoposide and Platinum Sponsor: Xiaorong Dong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials